Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy.
Di Sante S, Conners WP, Morgentaler A. Di Sante S, et al. Among authors: morgentaler a. J Sex Med. 2012 Feb;9(2):585-93. doi: 10.1111/j.1743-6109.2011.02557.x. Epub 2011 Dec 6. J Sex Med. 2012. PMID: 22145684
Occult prostate cancer in men with low serum testosterone levels.
Morgentaler A, Bruning CO 3rd, DeWolf WC. Morgentaler A, et al. JAMA. 1996 Dec 18;276(23):1904-6. JAMA. 1996. PMID: 8968017
Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients.
Khoudary KP, DeWolf WC, Bruning CO 3rd, Morgentaler A. Khoudary KP, et al. Among authors: morgentaler a. Urology. 1997 Sep;50(3):395-9. doi: 10.1016/S0090-4295(97)00280-X. Urology. 1997. PMID: 9301704
Is low serum free testosterone a marker for high grade prostate cancer?
Hoffman MA, DeWolf WC, Morgentaler A. Hoffman MA, et al. Among authors: morgentaler a. J Urol. 2000 Mar;163(3):824-7. J Urol. 2000. PMID: 10687985
The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL, Estrada C, Levine L, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Sep;170(3):795-8. doi: 10.1097/01.ju.0000082960.84075.54. J Urol. 2003. PMID: 12913700
Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats.
Rhoden EL, Gobbi D, Rhoden CR, Menti E, Roehe AN, Hartmann A, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Nov;170(5):2101-3. doi: 10.1097/01.ju.0000091827.97826.57. J Urol. 2003. PMID: 14532863
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251. N Engl J Med. 2004. PMID: 14749457 Review. No abstract available.
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2004 Feb;16(1):95-7. doi: 10.1038/sj.ijir.3901154. Int J Impot Res. 2004. PMID: 14963480
A 66-year-old man with sexual dysfunction.
Morgentaler A. Morgentaler A. JAMA. 2004 Jun 23;291(24):2994-3003. doi: 10.1001/jama.291.24.2994. JAMA. 2004. PMID: 15213212 No abstract available.
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback